Company · CIK 0001679082
Myovant Sciences Ltd.
Exchange
—
Entity type
operating
Fiscal year end
Mar 31
Headquarters
CA
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/AMyovant Sciences Ltd.0001193125-23-066981 · 69.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001140361-23-011046 · 644.8 KBSEC(opens sec.gov)
- SC 13D/AMyovant Sciences Ltd.0001193125-23-060730 · 87.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001140361-23-009304 · 181.2 KBSEC(opens sec.gov)
- SC 13GMyovant Sciences Ltd.0000899140-23-000441 · 47.8 KBSEC(opens sec.gov)
- SC 13G/AMyovant Sciences Ltd.0001193125-23-039167 · 53.1 KBSEC(opens sec.gov)
- SC 13G/AMyovant Sciences Ltd.0001274173-23-000018 · 10.1 KBSEC(opens sec.gov)
- SC 13GMyovant Sciences Ltd.0000318989-23-000038 · 8.9 KBSEC(opens sec.gov)
- SC 13G/AMyovant Sciences Ltd.0000846087-23-000026 · 32.9 KBSEC(opens sec.gov)
- 10-QQuarterly update0001679082-23-000025 · 9.8 MBSEC(opens sec.gov)
Insiders
- Altmeyer MarkDirector
- Arjona Ferreira Juan CamiloChief Medical Officer
- Curran TerrieDirector
- DeVeydt Wayne SDirector
- Dexcel Pharma Technologies Ltd.See remarks
- Dexxon Holdings Ltd.See remarks
- GUINAN MARKDirector
- Gulfo Adele M.Director
- HALVORSEN OLE ANDREASFormer 10% Owner
- KARBE FRANKPrincipal Fin'l & Accounting
Tickers
No tickers on record.
Addresses
business
SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE
LONDON, X0, SW1Y 4LB
mailing
SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE
LONDON, X0, SW1Y 4LB
Same industry